Comment on

• Discussing complementary therapies with cancer patients: what should we be talking about?

  Burstein HJ. Burstein HJ. J Clin Oncol. 2000 Jul;18(13):2501-4. doi: 10.1200/JCO.2000.18.13.2501. J Clin Oncol. 2000. PMID: 10893279 No abstract available.
• Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

  Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Richardson MA, et al. J Clin Oncol. 2000 Jul;18(13):2505-14. doi: 10.1200/JCO.2000.18.13.2505. J Clin Oncol. 2000. PMID: 10893280
• Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.

  Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T. Boon H, et al. J Clin Oncol. 2000 Jul;18(13):2515-21. doi: 10.1200/JCO.2000.18.13.2515. J Clin Oncol. 2000. PMID: 10893281